Skip to main content
Clinical Trials/ISRCTN59731654
ISRCTN59731654
Terminated
未知

Efficacy of a novel pancreaticojejunostomy technique in preventing pancreatic leakage and hemorrhage after pancreaticoduodenectomy: protocol for a randomised controlled trial

Shenjing Hospital of China Medical University0 sites390 target enrollmentDecember 6, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Periampullary tumors
Sponsor
Shenjing Hospital of China Medical University
Enrollment
390
Status
Terminated
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 6, 2019
End Date
June 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shenjing Hospital of China Medical University

Eligibility Criteria

Inclusion Criteria

  • 1\. Periampullary tumors indicated by at least two imaging examinations or pathological biopsy before surgery
  • 2\. \=18 years of age
  • 3\. Provision of written informed consent by patients or their legal guardians

Exclusion Criteria

  • 1\. Extensive tumor metastasis
  • 2\. Abnormal blood coagulation
  • 3\. Renal dysfunction (creatinine \>250 µmol/L)
  • 4\. Chronic liver disease
  • 5\. History of radiation therapy
  • 6\. American Society of Anesthesiologists (ASA) class IV\-V
  • 7\. Life expectancy \<48 hours
  • 8\. Lactating or pregnant women
  • 9\. Participation in other drug clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials